共 55 条
[2]
Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil
[J].
BMJ OPEN,
2017, 7 (12)
[6]
The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis
[J].
SCIENTIFIC REPORTS,
2017, 7
[7]
The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes
[J].
PLOS ONE,
2016, 11 (01)